MedTrace Logo

Pathologic-MRI Findings in Atypical IIDD

NCT03121105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2018-05-07

No results posted yet for this study

Summary

Our objective is to describe the pathologic and MRI findings in a series of patients with presumed demyelinating lesion of the central nervous system.

Conditions

  • Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    collaborator OTHER

  • Rennes University Hospital

    collaborator OTHER

  • University Hospital, Bordeaux

    collaborator OTHER

  • University Hospital, Limoges

    collaborator OTHER

  • Hospices Civils de Lyon

    collaborator OTHER

  • Centre Hospitalier Universitaire de Nīmes

    collaborator OTHER

  • Colmar Hospital

    collaborator UNKNOWN

  • Centre hospitalier de Perpignan

    collaborator OTHER

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • xavier AYRIGNAC, MD · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-12-01
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03121105 on ClinicalTrials.gov